Position in ARGX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$27,633,629
+$17,057,757 QoQ
Shares Held
29,785
+107.7% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#80
of 504 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mediolanum International Funds Ltd holds $75,305,474 across 10 Biotechnology names. ARGX ranks #1 (36.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
29,785 | $27,633,629 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
46,396 | $13,966,587 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,754 | $9,199,709 | |
| 4 | INCY |
Incyte Corp
|
76,627 | $8,686,436 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
15,940 | $5,924,419 | |
| 6 | ASND |
Ascendis Pharma A/S
|
11,697 | $3,119,823 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,776 | $2,869,112 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
28,940 | $2,358,899 |
All Filings in ARGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,633,629 | 29,785 | Shares | Sole | 2026-07-23 | |
| 2025-09-30 | $10,575,872 | 14,339 | Shares | Sole | 2025-11-04 | |
| 2024-09-30 | $8,664,606 | 15,984 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $4,598,847 | 10,694 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,514,393 | 11,466 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||